Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRKDC | P78527 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.32 |
| ▸ | ATM | Q13315 | 1/20 | 0.32 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.32 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.32 |
| ▸ | GABRB3 | P28472 | 1/20 | 0.32 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.32 |
| ▸ | GABRA3 | P34903 | 1/20 | 0.32 |
| ▸ | KAT6A | Q92794 | 1/20 | 0.32 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | CSF1R | P07333 | 1/20 | 0.31 |
| ▸ | FASN | P49327 | 1/20 | 0.31 |
| ▸ | MYC | P01106 | 1/20 | 0.31 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.31 |
| ▸ | MCL1 | Q07820 | 2/20 | 0.30 |
| ▸ | BCL2 | P10415 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17012215 | 0.96 | ALDH1A1 (0.34) | PRKDCALDH1A1ATMGABRA1GABRG2 | |
| SCHEMBL17132480 | 0.96 | PDK2 (0.35) | PRKDCALDH1A1ATMGABRA1GABRG2 | |
| SCHEMBL16484667 | 0.96 | ABCG2 (0.34) | PRKDCALDH1A1ATMGABRA1GABRG2 | |
| SCHEMBL23764184 | 0.95 | ALDH1A1 (0.34) | PRKDCALDH1A1ATMMEN1KMT2A | |
| SCHEMBL16484677 | 0.93 | ABCG2 (0.35) | ALDH1A1ATMMEN1KMT2ACSF1R | |
| SCHEMBL16484684 | 0.93 | ABCG2 (0.35) | ALDH1A1ATMMEN1KMT2ACSF1R | |
| SCHEMBL16484413 | 0.93 | ALDH1A1 (0.35) | PRKDCALDH1A1ATMGABRA1GABRG2 | |
| SCHEMBL17132478 | 0.92 | ADRA2C (0.36) | ALDH1A1GABRA1GABRG2GABRB3GABRA5 | |
| SCHEMBL16485035 | 0.91 | PRKDC (0.35) | PRKDCALDH1A1GABRA1GABRG2GABRB3 | |
| SCHEMBL23764343 | 0.91 | TUBB4A (0.33) | ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9935273-B2 | Fluoranthene derivative, light-emitting device material containing same, and light-emitting device | TORAY INDUSTRIES, INC. (JP) | 2018-04-03 | — | — | US | disclosed |
| US-9935273-B2 | Fluoranthene derivative, light-emitting device material containing same, and light-emitting device | TORAY INDUSTRIES, INC. (JP) | 2018-04-03 | — | — | US | disclosed |
| US-20150280139-A1 | FLUORANTHENE DERIVATIVE, LIGHT-EMITTING DEVICE MATERIAL CONTAINING SAME, AND LIGHT-EMITTING DEVICE | TORAY INDUSTRIES, INC. (JP) | 2015-10-01 | — | — | US | disclosed |
| US-20150280139-A1 | FLUORANTHENE DERIVATIVE, LIGHT-EMITTING DEVICE MATERIAL CONTAINING SAME, AND LIGHT-EMITTING DEVICE | TORAY INDUSTRIES, INC. (JP) | 2015-10-01 | — | — | US | disclosed |
| WO-2014057874-A1 | FLUORANTHENE DERIVATIVE, LUMINESCENT ELEMENT MATERIAL CONTAINING SAME, AND LUMINESCENT ELEMENT | 東レ株式会社 (JP) | 2014-04-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150280139-A1 | FLUORANTHENE DERIVATIVE, LIGHT-EMITTING DEVICE MATERIAL CONTAINING SAME, AND LIGHT-EMITTING DEVICE | FMNL1, AFF2, LEF1 | PRKDC 3703/4885ALDH1A1 1031/4885ATM 4142/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.